Cancer Genome Landscapes

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Science

• Publication date

  2013-03-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1126/science.1235122PMID 23539594PMCID PMC3749880
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• This copy is for your personal, non-commercial use only.

  2014cited by this paper
• Variable Clonal Repopulation Dynamics Influence Chemotherapy Response in Colorectal Cancer

  2013cited by this paper
• Single-molecule genomic data delineate patient-specific tumor profiles and cancer stem cell organization.

  2013cited by this paper
• Highly Recurrent TERT Promoter Mutations in Human Melanoma

  2013cited by this paper
• TERT Promoter Mutations in Familial and Sporadic Melanoma

  2013cited by this paper
• Cancer Pharmacogenomics: Early Promise, But Concerted Effort Needed

  2013cited by this paper
• Genomic landscape of non-small-cell lung cancer in smokers and never-smokers

  2013cited by this paper
• Half or more of the somatic mutations in cancers of self-renewing tissues originate prior to tumor initiation

  2013cited by this paper
• Whole-genome methylation analysis of benign and malignant colorectal tumours

  2013cited by this paper
• Epigenetic Reprogramming in Cancer

  2013cited by this paper
• Immunotherapy of cancer in 2012

  2012cited by this paper
• Mutual exclusivity analysis identifies oncogenic network modules.

  2012cited by this paper
• Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism.

  2012cited by this paper
• Whole-genome sequencing in autism identifies hot spots for de novo germline mutation.

  2012cited by this paper
• Molecular and functional characterization of early human hematopoiesis

  2012cited by this paper
• Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma

  2012cited by this paper
• Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes

  2012cited by this paper
• The landscape of cancer genes and mutational processes in breast cancer

  2012cited by this paper
• Whole Genome Analysis Informs Breast Cancer Response to Aromatase Inhibition

  2012cited by this paper
• Faculty Opinions recommendation of Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism.

  2012cited by this paper
• The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers

  2012cited by this paper
• From next-generation sequencing alignments to accurate comparison and validation of single-nucleotide variants: the pibase software

  2012cited by this paper
• IDH mutation impairs histone demethylation and results in a block to cell differentiation

  2012cited by this paper
• The Mutational Landscape of Lethal Castrate Resistant Prostate Cancer

  2012cited by this paper
• Comprehensive molecular characterization of human colon and rectal cancer

  2012cited by this paper
• Cancer Exome Analysis Reveals a T Cell Dependent Mechanism of Cancer Immunoediting

  2012cited by this paper
• Comprehensive molecular portraits of human breast tumors

  2012cited by this paper
• Direct mutation analysis by high-throughput sequencing: from germline to low-abundant, somatic variants.

  2012cited by this paper
• Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.

  2012cited by this paper
• Whole genome sequencing for quantifying germline mutation frequency in humans and model species: cautious optimism.

  2012cited by this paper
• The mouse lymph node as an ectopic transplantation site for multiple tissues

  2012cited by this paper
• Germline mutations in the proof-reading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas

  2012cited by this paper
• Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.

  2012cited by this paper
• Resistance to BRAF Inhibition in BRAF-Mutant Colon Cancer Can Be Overcome with PI3K Inhibition or Demethylating Agents

  2012cited by this paper
• Applying What We Know to Accelerate Cancer Prevention

  2012cited by this paper
• Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer

  2012cited by this paper
• Single-cell exome sequencing reveals single-nucleotide mutation characteristics of a kidney tumor.

  2012cited by this paper
• A cluster of cooperating tumor-suppressor gene candidates in chromosomal deletions

  2012cited by this paper
• Checkpoint control and cancer

  2012cited by this paper
• IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype

  2012cited by this paper
• Mutational Processes Molding the Genomes of 21 Breast Cancers

  2012cited by this paper
• The Life History of 21 Breast Cancers

  2012cited by this paper
• Computational drug design targeting protein-protein interactions.

  2012cited by this paper
• Genomic landscape of non-small cell lung cancer in smokers and never-smokers.

  2012cited by this paper
• Exploiting the mutanome for tumor vaccination.

  2012cited by this paper
• Signaling mechanisms controlling cell fate and embryonic patterning.

  2012cited by this paper
• Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing.

  2012cited by this paper
• Somatic Histone H3 Alterations in Paediatric Diffuse Intrinsic Pontine Gliomas and Non-Brainstem Glioblastomas

  2012cited by this paper
• The origin and evolution of mutations in acute myeloid leukemia.

  2012cited by this paper
• Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma.

  2012cited by this paper
• Association between KRAS codon 13 mutations and clinical response to anti-EGFR treatment in patients with metastatic colorectal cancer: results from a meta-analysis

  2012cited by this paper
• Recurrent Hemizygous Deletions in Cancers May Optimize Proliferative Potential

  2012cited by this paper
• Exome sequencing of hepatitis B virus–associated hepatocellular carcinoma

  2012cited by this paper
• Combined genetic inactivation of β2-Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma.

  2011cited by this paper
• Scaling rules for diffusive drug delivery in tumor and normal tissues

  2011cited by this paper
• Somatic Mutations in the Chromatin Remodeling Gene ARID1A Occur in Several Tumor Types

  2011cited by this paper
• Expression of tumour-specific antigens underlies cancer immunoediting

  2011cited by this paper
• Using a priori knowledge to align sequencing reads to their exact genomic position

  2011cited by this paper
• RECURRENT MUTATIONS IN THE U2AF1 SPLICING FACTOR IN MYELODYSPLASTIC SYNDROMES

  2011cited by this paper
• The DNA methylome

  2011cited by this paper
• Frequent pathway mutations of splicing machinery in myelodysplasia

  2011cited by this paper
• Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts.

  2011cited by this paper
• Biomarkers for early detection and as surrogate endpoints in cancer prevention trials: issues and opportunities.

  2011cited by this paper
• Identifying cancer driver genes in tumor genome sequencing studies

  2011cited by this paper
• Analysis of the Coding Genome of Diffuse Large B-Cell Lymphoma

  2011cited by this paper
• The Mutational Landscape of Head and Neck Squamous Cell Carcinoma

  2011cited by this paper
• Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion

  2011cited by this paper
• DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors

  2011cited by this paper
• Circulating tumor cells: approaches to isolation and characterization

  2011cited by this paper
• Improved survival with vemurafenib in melanoma with BRAF V600E mutation.

  2011cited by this paper
• Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development

  2011cited by this paper
• Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling.

  2011cited by this paper
• The Genetic Landscape of the Childhood Cancer Medulloblastoma

  2011cited by this paper
• Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1

  2011cited by this paper
• Tumour evolution inferred by single-cell sequencing

  2011cited by this paper
• Developmental and pathological angiogenesis.

  2011cited by this paper
• Frequent mutation of histone modifying genes in non-Hodgkin lymphoma

  2011cited by this paper
• Feature-based classifiers for somatic mutation detection in tumour–normal paired sequencing data

  2011cited by this paper
• Genetic variegation of clonal architecture and propagating cells in leukaemia

  2011cited by this paper
• Altered Telomeres in Tumors with ATRX and DAXX Mutations

  2011cited by this paper
• Targeted enrichment of genomic DNA regions for next-generation sequencing

  2011cited by this paper
• Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer

  2011cited by this paper
• Therapeutic potential of PARP inhibitors for metastatic breast cancer

  2011cited by this paper
• Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

  2010cited by this paper
• Alternative lengthening of telomeres: models, mechanisms and implications

  2010cited by this paper
• Fibroblast growth factor signalling: from development to cancer

  2010cited by this paper
• ARID1A mutations in endometriosis-associated ovarian carcinomas.

  2010cited by this paper
• Evolution of resistance and progression to disease during clonal expansion of cancer.

  2010cited by this paper
• Uso racional de medicamentos antineoplásicos y acciones judiciales en el estado de Sao Paulo, Sureste de Brasil

  2010cited by this paper
• Distant Metastasis Occurs Late during the Genetic Evolution of Pancreatic Cancer

  2010cited by this paper
• Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma

  2010cited by this paper
• DNMT3A mutations in acute myeloid leukemia.

  2010cited by this paper
• The patterns and dynamics of genomic instability in metastatic pancreatic cancer

  2010cited by this paper
• Rational use of anticancer drugs and patient lawsuits in the state of São Paulo, Southeastern Brazil.

  2010cited by this paper
• Advances in understanding cancer genomes through second-generation sequencing

  2010cited by this paper
• The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate.

  2010cited by this paper
• COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer

  2010cited by this paper
• Multiple roles of ATM in monitoring and maintaining DNA integrity

  2010cited by this paper
• Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC.

  2010cited by this paper
• Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma.

  2010cited by this paper

• Quantifying rate-limiting genetic variation in breast and ovarian tumourigenesis.

  2026cites this paper
• Mapping biology in space: from spatial transcriptomics platforms to analytical tools and databases.

  2026cites this paper
• Cancer Neoantigen Vaccines Emerge Efficacious.

  2026cites this paper
• Bioinformática en cáncer

  2026cites this paper
• The oncogenome of the domestic cat.

  2026cites this paper
• Dual Confinement-Enhanced Multiple Single Nucleotide Variant Detection at the Single-Particle Level.

  2026cites this paper
• Piecing Together the Puzzles: Aryl Hydrocarbon Receptor-Mediated Genetic and Epigenetic Signatures in Dioxin-Induced Carcinogenicity- A Systematic Review and Meta-Analysis.

  2026cites this paper
• CRISPR-enhanced assessment of variants of unknown significance nominates oncology therapeutic targets and drug repositioning opportunities

  2026influential citation
• Circulating tumor DNA-guided early detection and minimal residual disease monitoring in pancreatic and biliary cancers: evidence, barriers, and opportunities.

  2026cites this paper
• Identification of public neoantigens with broad HLA class I coverage as candidates for off-the-shelf cancer vaccine development in colorectal cancer.

  2026cites this paper
• Biomarkers in Colorectal Cancer: Clinically Relevant Diagnostic and Prognostic Molecular Features, and the Future of Precision Medicine

  2026cites this paper
• Discover personalized drug opportunity and optimized tumor-infiltrating lymphocyte therapy for rare cancer: an organoid-based whole-journey clinical mapping study in a neuroendocrine cancer patient

  2026cites this paper
• Loss of XRCC1 promotes cGAS/STING mediated innate immune signaling in gastric cancer.

  2026cites this paper
• FusionPath: Gene fusion pathogenicity prediction using protein structural data and contextual protein embeddings

  2026cites this paper
• HyperNetWalk: A Unified Framework for Personalized and Population-Level Cancer Driver Gene Identification via Multi-Network Hypergraph Diffusion

  2026cites this paper
• Mutational Landscape of Colorectal Tumors From Individuals With Unexplained Adenomatous or Serrated Colorectal Polyposis.

  2026cites this paper
• Characterizing p53 structural insights of variants in vertebrates that interfere its regulatory interaction with Mdm2.

  2026cites this paper
• Predicting Gene Mutations in Colon Cancer Using Long-Term Temporal Dependency Learning on a Directed Co-Occurrence Asymmetry Graph

  2026cites this paper
• Multi-objective two-archive evolutionary algorithm to optimize the discovery of gene networks involved in cancer survival

  2026cites this paper
• Colorectal cancer as a complex adaptive system: integrating the hallmarks of cancer with complexity theory.

  2026cites this paper
• Enterococcus faecalis-induced bystander effect causes epigenetic alterations leading to aberrant TGF-β signaling and epithelial-mesenchymal transition.

  2026cites this paper
• Systematic analysis of functional genetic and epigenetic variants in colorectal cancer.

  2026cites this paper
• Editorial: Exploiting non-oncogene addiction for overcoming drug resistance in metastatic tumors

  2026cites this paper
• A hormetic transcriptional program coregulates invasion, proliferation and dormancy to define metastatic potential.

  2026cites this paper
• Differential interfacial tension between oncogenic and wild-type populations forms the mechanical basis of tissue-specific oncogenesis in epithelia

  2026cites this paper
• Multi-Scale Mapping of Gene Expression from Whole-slide Images for Identifying Phenotype-Associated Subpopulations.

  2026cites this paper
• OnCorr: A pan-cancer mRNA-protein correlation tool for precision oncology.

  2026cites this paper
• Mutational signatures in cancer genomes alter protein sequence motifs in cellular signaling networks

  2026cites this paper
• Clonal Complexity Defines Distinct Tumor‐Intrinsic Biology and Prognosis in Diffuse Large B‐Cell Lymphoma

  2026cites this paper
• Feature-Based Classification of Cancer Drug Target Genes Using Machine Learning Approaches

  2026cites this paper
• A Comprehensive Guide on Epigenetics' Precision Role in Uncommon "Rare" Cancers' Biology and Treatment Frontiers.

  2026cites this paper
• Valproate Releases the Latent Differentiation Capacity of Neuroblastoma by Targeting SP1/CDK4 Signaling

  2026cites this paper
• Toward Personalized Treatment of Urogenital Cancers: The Role of Patient-Derived Organoids.

  2026cites this paper
• Hyaluronic Acid‐Coated DNA Nanoflowers as Smart Nanocarriers for Deep Tumor Penetration and Enhanced Gene Therapy in Pancreatic Cancer

  2026cites this paper
• Pan-cancer analysis of integrin alpha family and prognosis validation in head and neck squamous cell carcinoma

  2026cites this paper
• Role of tumor-infiltrating lymphocytes and miR-155 in breast cancer: Insights into carcinogenesis and their potential as prognostic biomarkers (Review)

  2026cites this paper
• The multistep pathogenic hypothesis of amyotrophic lateral sclerosis is incompatible with the epidemiological data

  2026cites this paper
• A proteogenomic atlas of 1032 brain metastases identifies molecular subtypes, immune landscapes, and therapeutic vulnerabilities

  2026cites this paper
• Genomic biomarkers for immunotherapy response in pediatric solid tumors

  2026cites this paper
• Comparison of Molecular Alterations and Survival Analysis in Uterine Endometrioid Carcinomas and Serous Carcinomas: An In Silico Study

  2026cites this paper
• Therapeutic synergies that overcome carboplatin resistance in triple-negative breast cancer.

  2026cites this paper
• Comprehensive multi-omics analysis reveals RUNX1's prognostic value, immune associations, and MUC13-Mediated mechanistic role in hepatocellular carcinoma pathogenesis

  2026cites this paper
• The signal hijacker: How tumors co-opt chemical, electrical, and mechanical cues to thrive.

  2026cites this paper
• Interpreting cancer genetics through a two-step "evolutionary cascade hypothesis": bridging neutral and selective perspectives.

  2026cites this paper
• Reprogramming tumor immunity through APOBEC3s-mediated mutagenesis: from genome instability to immune checkpoint interactions.

  2026cites this paper
• Evidence that extra copies of chromosome 1q play a role in the early phases of pancreatic neoplasia.

  2026cites this paper
• From the Hallmarks of Cancer to the Survival System: A Paradigmatic Reconstruction of Oncological Theory through the Existential Crisis-Driven Survival (ECDS) Framework

  2026cites this paper
• Advances in Cancer Biomarkers: Diagnostic, Prognostic, and Therapeutic Implications

  2026cites this paper
• AMDRP: adaptive drug feature fusion and multihead bidirectional cross-attention network for drug-cancer cell response prediction.

  2026cites this paper
• Contextual Invertible World Models: A Neuro-Symbolic Agentic Framework for Colorectal Cancer Drug Response

  2026cites this paper
• Somatic mutations from pathogenesis to forensic medicine: opportunities, challenges, and future directions.

  2026cites this paper
• A hotspot phosphorylation site on SHP2 drives oncoprotein activation and drug resistance.

  2026cites this paper
• UNITe: exploiting conserved links between oncogenesis and homeostasis to identify novel cancer drivers

  2026cites this paper
• Genome agnostic, multi-level non-oncogene addiction-based systems pharmacology for rescuing metastatic relapsed/refractory neoplasias

  2026cites this paper
• Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBC.

  2026cites this paper
• Does childhood obesity foreshadow a future time-bomb of early and more aggressive cancers?

  2026cites this paper
• Detection of structural DNA variants in medulloblastomas using optical genome mapping

  2026cites this paper
• Selective sweep probabilities in spatially expanding populations

  2026cites this paper
• AI-driven radiogenomics in gynecologic oncology: from radiological digital biopsy to a new paradigm in precision therapy.

  2026cites this paper
• Dysregulated expression of the tumor suppressor p14ARF in cancer provides an effective target for TCR-T cell therapeutics

  2026cites this paper
• Cerebrospinal fluid cfDNA-based molecular assessment of resection extent and prognosis in glioma.

  2026cites this paper
• A Global Assessment of the Transcription-Dependent Single Nucleotide Variants Relies on the Characteristics of RNA-Sequencing Technologies.

  2026cites this paper
• A novel mouse cell line model reveals the tumor intrinsic and immune characteristics of EGFR-mutant lung cancer

  2026cites this paper
• RAG-msCNN: predicting protein-DNA binding sites by integration of retrieval-augmented generation (RAG) with protein language models and the multi-scale separable convolutional neural network

  2026cites this paper
• Neo-Cysteine Molecular Glues for Targeting Mutated SMAD4 Protein.

  2026cites this paper
• Anchored random reverse primer sequencing for quantitative detection of novel gene fusions.

  2026cites this paper
• Clinical Applications of Immunogenomics in Hepatocellular Carcinoma.

  2026influential citation
• MODCAN: driver gene identification based on multi-omics features and differential co-association networks for tumor subtypes

  2026cites this paper
• EcDNA-borne structural variants drive oncogenic fusion transcript amplification.

  2026cites this paper
• GRAFT: a graph-aware fusion transformer for cancer driver gene prediction

  2026cites this paper
• Small Nucleotide Variant Analysis Using RNA Fusion Panel (SMURF): Making the Most of RNAseq Data in Solid Tumours

  2026cites this paper
• ONCOPLEX: an oncology-inspired hypergraph model integrating diverse biological knowledge for cancer driver gene prediction

  2026cites this paper
• Spatial transcriptome and single-cell sequencing reveal the role of nucleotide metabolism in breast cancer progression and tumor microenvironment

  2026cites this paper
• Bispecific antibodies and CAR T cells targeting a TP53 mutation–associated neoantigen show discordant affinity requirements

  2026cites this paper
• Oncogenic Alterations in PI3K Signaling Emulated Optogenetically Recapitulate Some Phenotypic Changes in Mammary Epithelia.

  2026cites this paper
• Integrating evidence from protein domains to identify cancer driver mutations

  2026cites this paper
• Transcription-Coupled Repair Promotes the Retention of Mutations in Coding Regions During Replication Stress

  2026cites this paper
• Defining the genome-wide mutagenic impact of APOBEC3 enzymes.

  2025cites this paper
• Cancer chemoprevention: signaling pathways and strategic approaches

  2025cites this paper
• Upfront liquid biopsy in patients with advanced solid tumors who were not feasible for tissue-based next-generation sequencing.

  2025cites this paper
• Perspectives on cancer therapy—synthetic lethal precision medicine strategies, molecular mechanisms, therapeutic targets and current technical challenges

  2025cites this paper
• Clinical Impact of Somatic Genomic Variants of Oncogenes and Tumor Suppressor Genes in Previously Treated Advanced Non–Small Cell Lung Cancer

  2025cites this paper
• Identification of Driver Mutations and Risk Stratification in Lung Adenocarcinoma via Liquid Biopsy

  2025cites this paper
• Understanding developing kidneys and Wilms tumors one cell at a time.

  2025cites this paper
• The Warburg hypothesis and the emergence of the mitochondrial metabolic theory of cancer

  2025cites this paper
• PAQR4: From spatial regulation of cell signaling to physiological homeostasis and diseases.

  2025cites this paper
• Aromatics from fossil fuels and breast cancer.

  2025cites this paper
• Emerging Roles of ACTL6A as an Oncogenic Hub: Transcriptional Regulation and Beyond.

  2025cites this paper
• The impact of gut microbial short-chain fatty acids on colorectal cancer development and prevention

  2025cites this paper
• Werner helicase as a therapeutic target in mismatch repair deficient colorectal cancer.

  2025cites this paper
• The spindle assembly checkpoint: Molecular mechanisms and kinase-targeted drug discovery.

  2025cites this paper
• Multiple data sets to explore the key molecules and mechanism of lymph node metastasis in gastric cancer

  2025cites this paper
• The Hallmarks of Cancer as Eco-Evolutionary Processes.

  2025cites this paper
• Identification of aberrantly expressed genes during aging in the mouse heart via integrated bioinformatics analysis

  2025cites this paper
• Six Fundamental Behaviors of Immune-Pathogen Feedback Circuits

  2025cites this paper
• Addressing Challenges in Targeted Therapy for Metastatic Colorectal Cancer

  2025cites this paper
• A 3D Genome Atlas of Genetic Variants and Their Pathological Effects in Cancer

  2025cites this paper
• A phase Ia study of the MEK1/2 inhibitor PD-0325901 with the c-MET inhibitor crizotinib in patients with advanced solid cancers

  2025cites this paper
• Severus detects somatic structural variation and complex rearrangements in cancer genomes using long-read sequencing

  2025cites this paper
• Clinical characterization and therapeutic targeting of fusion genes in oncology

  2025cites this paper